Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Short Term Effects of an AKT Inhibitor (AZD5363) on Biomarkers of the AKT Pathway and Anti-tumour Activity in a Breast Cancer Paired Biopsy Study

NCT02077569 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT02077569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02077569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Short Term Effects of an AKT Inhibitor (AZD5363) on Biomarkers of the AKT Pathway and Anti-tumour Activity in a Breast Cancer Paired Biopsy Study
Lead sponsor
University of Nottingham
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
February 21, 2017
Enrollment
48 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer